Markets

Eastman Chemical (EMN) Set to Increase Prices of Amines

Eastman Chemical CompanyEMN is set to increase prices of certain products in North and Latin America. The price hike, effective from Oct 1 or as contracts permit, is due to elevated operating costs, especially in raw materials.

The company will increase the price of Tri-n-butylamine and Diisopropylamine by 6 cents per lb in North and Latin America. Prices of Di-n-butylamine and Monoisopropylamine will rise by 5 cents per lb in both North and Latin America. Mono-n-butylamine's price will be hiked by 4 cents per lb in both North and Latin America.

Eastman Chemical's shares have moved up 3.3% over the past three months, underperforming the industry 's 9.7% gain.

Eastman Chemical expects to drive growth on the back of innovation and high-margin products amid an uncertain global business environment. Eastman Chemical believes that disciplined capital allocation and aggressive cost-management policies might contribute to earnings and offset challenges faced by the company in Fibers and ethylene pricing.

Factoring in strong first-half 2017 results, the company expects adjusted earnings per share for 2017 to grow 10-12% year over year, up from its earlier view of 8-12%.

Eastman Chemical remains focused on cost-cutting and productivity actions. The company aims to achieve $100 million of cost savings in 2017. The company remains committed to reduce debt and boost shareholder returns.

Eastman Chemical is also gaining from synergies of acquisitions, especially Taminco Corporation. The Taminco acquisition has provided attractive cost and revenue synergy opportunities.

However, Eastman Chemical continues to witness pricing pressure in some businesses. Lower prices of acetate tow are hurting its Fibers unit. Moreover, the company expects ethylene prices to be lower in second-half 2017 vis-à-vis the first half. As such, ethylene margins are expected to be under pressure in the second half. The company is also exposed to a volatile raw material pricing environment.

Eastman Chemical Company Price and Consensus

Eastman Chemical Company Price and Consensus | Eastman Chemical Company Quote

Zacks Rank & Key Picks

Eastman Chemical currently carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the chemical space are Kronos Worldwide KRO , Koppers Holdings Inc. KOP and Arkema S.A. ARKAY .

Kronos has an expected long-term earnings growth of 5% and sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here.

Koppers has an expected long-term earnings growth of 18% and flaunts a Zacks Rank #1.

Arkema has an expected long-term earnings growth of 12.8% and carries a Zacks Rank #2 (Buy).

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Eastman Chemical Company (EMN): Free Stock Analysis Report

Kronos Worldwide Inc (KRO): Free Stock Analysis Report

Koppers Holdings Inc. (KOP): Free Stock Analysis Report

Arkema SA (ARKAY): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ARKAY KOP EMN KRO

Other Topics

Stocks

Latest Markets Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More